Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Colon & Rectum (Late Stage^), 2017-2021

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Percentlate
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 21.8 (21.8, 21.9) N/A 83,825 59.8
Puerto Rico 6 18.4 (17.8, 19.0) N/A 767 49.2
District of Columbia 6 19.3 (17.8, 20.9) 42 (27, 50) 127 53.7
Alabama 6 22.1 (21.6, 22.7) 23 (17, 30) 1,361 54.8
Connecticut 3 19.0 (18.5, 19.6) 45 (38, 48) 864 56.0
Nevada 6 19.2 (18.6, 19.9) 44 (37, 48) 688 56.5
Iowa 3 22.8 (22.1, 23.5) 18 (10, 27) 884 56.6
Vermont 6 18.6 (17.3, 20.1) 48 (33, 50) 160 56.8
Oklahoma 6 23.0 (22.4, 23.7) 15 (9, 24) 1,044 56.9
New York 3 20.4 (20.2, 20.7) 36 (32, 40) 5,022 57.0
Kentucky 3 26.2 (25.6, 26.9) 3 (2, 6) 1,427 57.1
Minnesota 6 20.7 (20.2, 21.2) 34 (28, 40) 1,377 57.1
California 3 19.3 (19.1, 19.4) 43 (39, 47) 8,438 57.2
New Mexico 3 18.9 (18.1, 19.7) 47 (38, 49) 484 57.2
New Jersey 3 21.8 (21.4, 22.2) 26 (20, 30) 2,489 57.6
Nebraska 6 22.7 (21.8, 23.7) 19 (9, 29) 509 57.8
Hawaii 3 22.1 (21.2, 23.2) 21 (12, 34) 409 57.9
Louisiana 3 25.8 (25.2, 26.5) 4 (2, 7) 1,402 57.9
Georgia 3 22.9 (22.5, 23.3) 17 (12, 22) 2,692 58.3
Maine 6 20.5 (19.6, 21.5) 35 (24, 45) 393 58.5
Virginia 6 20.0 (19.6, 20.4) 38 (33, 43) 2,012 59.1
Arizona 6 19.0 (18.6, 19.4) 46 (40, 48) 1,640 59.2
Utah 3 17.3 (16.7, 18.1) 50 (47, 50) 491 59.2
Delaware 6 19.9 (18.8, 21.1) 39 (27, 48) 256 59.3
Maryland 6 21.0 (20.5, 21.5) 31 (26, 37) 1,530 59.6
West Virginia 6 26.7 (25.7, 27.6) 2 (2, 6) 657 59.8
Florida 6 21.7 (21.4, 21.9) 27 (22, 30) 6,397 59.9
Michigan 6 21.3 (20.9, 21.7) 29 (24, 34) 2,665 60.1
Rhode Island 6 19.7 (18.6, 20.8) 40 (30, 48) 271 60.3
Kansas 6 23.8 (23.0, 24.5) 13 (6, 20) 803 60.6
Arkansas 6 25.1 (24.3, 25.8) 6 (3, 10) 920 60.7
Alaska 6 25.2 (23.5, 27.0) 5 (2, 18) 184 60.8
Texas 3 23.0 (22.7, 23.2) 16 (13, 21) 6,767 60.8
New Hampshire 6 20.7 (19.8, 21.8) 33 (21, 44) 374 60.9
Wyoming 6 21.6 (20.0, 23.3) 28 (9, 44) 149 60.9
Montana 6 22.5 (21.3, 23.7) 20 (9, 34) 309 61.0
Illinois 3 23.8 (23.4, 24.1) 11 (7, 15) 3,627 61.2
Washington 5 21.0 (20.5, 21.4) 32 (27, 37) 1,814 61.2
Ohio 6 23.9 (23.5, 24.3) 10 (7, 14) 3,496 61.3
Wisconsin 6 21.3 (20.8, 21.8) 30 (23, 35) 1,540 61.3
Oregon 6 20.1 (19.5, 20.7) 37 (31, 44) 1,036 61.4
South Carolina 6 22.0 (21.5, 22.5) 25 (18, 30) 1,392 61.4
Tennessee 6 23.8 (23.3, 24.3) 12 (7, 17) 1,964 61.4
North Dakota 6 24.0 (22.5, 25.6) 9 (3, 26) 208 61.7
Mississippi 6 29.0 (28.2, 29.8) 1 (1, 1) 1,024 62.0
Colorado 6 19.5 (19.0, 20.0) 41 (36, 48) 1,216 62.2
North Carolina 6 22.1 (21.7, 22.5) 24 (18, 28) 2,734 62.2
Pennsylvania 6 23.4 (23.0, 23.7) 14 (10, 19) 3,956 62.4
Idaho 3 22.1 (21.2, 23.1) 22 (13, 34) 454 62.5
Missouri 6 24.5 (24.0, 25.1) 8 (5, 12) 1,845 62.8
South Dakota 6 25.0 (23.6, 26.4) 7 (2, 18) 264 63.3
Indiana 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 10/07/2024 1:16 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.
Source: SEER and NPCR data. For more specific information please see the table.

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top